2017
DOI: 10.22317/jcms.12201701
|View full text |Cite
|
Sign up to set email alerts
|

Role of bariatric surgery in treatment of non-alcoholic fatty liver disease

Abstract: The prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) is increasing due to increasing of morbid obesity prevalence worldwide. It has been demonstrated that weight loss is the corner stone of NAFLD/NASH treatment. Various options are available for weight loss in obese patients, such as life style modification, pharmacotherapy, endoscopic interventions and bariatric/metabolic surgery. Performing bariatric/meta bolic surgery only for NAFLD/NASH treatment is on debate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 85 publications
(120 reference statements)
0
0
0
Order By: Relevance